Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Isis Pharmaceuticals initiates clinical study of ISIS-SMN Rx in infants with SMA
Isis Pharmaceuticals initiates clinical study of ISIS-SMN Rx in infants with SMA
Isis Pharmaceuticals initiates clinical study of ISIS-SMN Rx in infants with SMA
Submitted by
admin
on April 23, 2013 - 10:46am
Source:
Yahoo/Fly on the Wall
News Tags:
ISIS-SMN
Isis Pharmaceuticals
spinal muscular atrophy
SMA
Headline:
Isis Pharmaceuticals initiates clinical study of ISIS-SMN Rx in infants with SMA
Do Not Allow Advertisers to Use My Personal information
